查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太地區診斷質譜和層析法分析市場按產品類型、應用類型和國家分類的分析與預測（2024-2033 年）
市場調查報告書
商品編碼
1657956

亞太地區診斷質譜和層析法分析市場按產品類型、應用類型和國家分類的分析與預測（2024-2033 年）

Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market: Focus on Product Type, Application Type, and Country - Analysis and Forecast, 2024-2033
出版日期: | 出版商: BIS Research | 英文 56 Pages | 商品交期: 1-5個工作天內

價格

到 2024 年，亞太地區質譜和層析法診斷市場規模預計將達到 1.542 億美元。

預計到 2033 年，該市場規模將達到 4.287 億美元，2024-2033 年預測期內的複合年成長率為 12.04%。亞太地區質譜（MS）和層析法市場是分析和生命科學儀器領域的主要部分，為生物和化學對象的分離、鑑定和定量提供尖端解決方案。製藥、環境監測、診斷和食品安全等許多行業都受益於這些技術。

質譜法和層析法通常不會單獨使用，而是整合到診斷工作流程中。例如，液相層析法質譜法（LC-MS）是一種分析複雜樣品的高效技術，因為它結合了質譜的檢測能力和液相層析法的分離效率。這種整合在臨床環境中尤其有益，因為對患者樣本進行高通量分析可以實現準確的診斷和治療計劃。

主要市場統計數據
預測期 2024-2033
2024 年評估 1.542億美元
2033 年預測 4.287億美元
複合年成長率 12.04％

亞太地區層析法和質譜技術的主要診斷應用包括維生素分析、荷爾蒙分析和生物標記發現。隨著精準醫療、代謝體學和蛋白​​質組學的日益普及，這些技術預計將因醫療保健投資的增加、技術進步和先進診斷工具的普及而經歷廣泛的成長。

由於臨床診斷的複雜性日益增加以及精準醫療的需求，亞太地區診斷市場的質譜和層析法正在顯著成長。質譜 (MS) 和層析法是化學和生物物質的分離、鑑定和定量所必需的，因此是診斷和監測許多疾病（包括癌症、代謝紊亂和感染疾病）的重要工具。

液相層析法質譜 (LC-MS) 等技術廣泛應用於診斷工作流程，可實現患者樣本的高通量和精確分析。這些混合系統結合了質譜和分離功能，為臨床環境中複雜樣本的分析提供了完整的解決方案。它在蛋白質組學、代謝體學和生物標記發現、增強診斷能力和個人化醫療方面發揮關鍵作用。

有針對性的藥物測試、代謝分析、維生素和荷爾蒙分析是重要的診斷應用。人們對早期疾病檢測和個人化治療方案的關注度日益提高，推動了對這些尖端診斷工具的需求。

政府的早期檢測計劃、擴大醫療保健基礎設施以及自動化和人工智慧主導的分析等技術發展都在促進市場發展。隨著亞太地區醫療保健系統採用更複雜的診斷工具，改善全部區域的患者治療效果和醫療保健效果，質譜和層析法市場預計將繼續成長。

本報告研究了亞太地區診斷質譜和層析法市場，並概述了市場概況、產品類型、應用類型和國家的趨勢，以及參與市場的公司概況。

目錄

執行摘要

第 1 章 診斷市場中的質譜和層析法：產業展望

  • 市場概況
  • 主要趨勢
  • 主要趨勢的機會評估
  • 產品基準
  • 監管狀態
    • 亞太法規結構

2. 診斷市場中的質譜和層析法（按地區）

  • 區域概況
  • 亞太地區

3. 診斷市場中的質譜和層析法：競爭基準化分析和公司概況

  • 競爭格局
    • 夥伴關係、合作和業務擴展
    • 新服務
    • 合併和收購
    • 監管部門核准
  • 關鍵策略和發展
  • 企業競賽矩陣
  • 企業市場占有率分析
  • 公司簡介
    • Shimadzu Corporation

第4章調查方法

Product Code: BHL2516SS

Introduction to Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market

The Asia-Pacific mass spectrometry and chromatography in diagnostics market was valued at $154.2 million in 2024 and is expected to reach $428.7 million by 2033, growing at a CAGR of 12.04% during the forecast period 2024-2033. The APAC Mass Spectrometry (MS) and Chromatography Market is a key player in the analytical and life sciences instrumentation sector, providing cutting-edge solutions for the separation, identification, and quantification of biological and chemical objects. Numerous industries, including pharmaceuticals, environmental monitoring, diagnostics, and food safety, have advanced significantly as a result of these technologies.

Instead of being used separately, mass spectrometry and chromatography are usually incorporated into workflows in diagnostics. For example, liquid chromatography-mass spectrometry (LC-MS) is a highly effective method for complex sample analysis because it combines the detection capabilities of mass spectrometry with the separation efficiency of liquid chromatography. In clinical settings, where accurate diagnosis and treatment planning are made possible by high-throughput analysis of patient samples, this integration is especially beneficial.

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$154.2 Million
2033 Forecast$428.7 Million
CAGR12.04%

Important diagnostic uses for chromatography and mass spectrometry in the APAC region include vitamin profiling, hormone analysis, and biomarker discovery. With increasing adoption in precision medicine, metabolomics, and proteomics, these technologies are expected to see widespread growth, driven by rising healthcare investments, technological advancements, and expanding access to advanced diagnostic tools.

Market Introduction

The market for APAC mass spectrometry and chromatography in diagnostics is expanding significantly due to the rising complexity of clinical diagnostics and the growing need for precision medicine. Mass spectrometry (MS) and chromatography are vital tools in the diagnosis and monitoring of many diseases, such as cancer, metabolic disorders, and infectious diseases, because they are necessary for the separation, identification, and quantification of chemical and biological substances.

High-throughput, precise analysis of patient samples is made possible by technologies like liquid chromatography-mass spectrometry (LC-MS), which are being widely used in diagnostic workflows. These hybrid systems provide complete solutions for intricate sample analysis in clinical settings by fusing mass analysis and separation capabilities. They play a key role in proteomics, metabolomics, and biomarker discovery, which enhances diagnostic capabilities and personalized medicine.

Targeted drug testing, metabolic analysis, and vitamin and hormone profiling are important diagnostic applications. The need for these cutting-edge diagnostic tools is being driven by the increased focus on early disease detection and individualized treatment plans.

Government programs for early detection, growing healthcare infrastructure, and technological developments like automation and AI-driven analytics all contribute to market expansion. The market for mass spectrometry and chromatography is expected to keep growing as APAC's healthcare systems embrace more sophisticated diagnostic tools, which will enhance patient outcomes and healthcare effectiveness throughout the region.

Market Segmentation

Segmentation 1: by Product Type

  • Sample Preparation
  • Mass Spectrometry and Chromatography

Segmentation 2: by Application Type

  • Therapeutic Drug Monitoring
  • Vitamins
  • Hormones
  • Methylmalonic Acid
  • Immunosuppressants
  • Others

Segmentation 3: by Region

  • Asia-Pacific
    • Japan
    • India
    • China
    • Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific mass spectrometry and chromatography in diagnostics market has been segmented based on various categories, such as by product type, application type, and country.

Competitive Strategy: The Asia-Pacific mass spectrometry and chromatography market consists of various public and few private companies. Key players in the mass spectrometry and chromatography in diagnostics market analyzed and profiled in the study involve established players that offer various kinds of products.

Table of Contents

Executive Summary

Scope and Definition

1 Mass Spectrometry and Chromatography in Diagnostics Market: Industry Outlook

  • 1.1 Market Overview
  • 1.2 Key Trends
    • 1.2.1 Shift toward Utilization of Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) as Standard Technique in Diagnostics
    • 1.2.2 Utilization of Automated Sample Preparation Technologies
  • 1.3 Opportunity Assessment of Key Trends
  • 1.4 Product Benchmarking
  • 1.5 Regulatory Landscape
    • 1.5.1 Regulatory Framework in Asia-Pacific
      • 1.5.1.1 China

2 Mass Spectrometry and Chromatography in Diagnostics Market (by Region)

  • 2.1 Regional Summary
  • 2.2 Asia-Pacific
    • 2.2.1 Regional Overview
    • 2.2.2 Driving Factors for Market Growth
    • 2.2.3 Factors Challenging the Market
    • 2.2.4 By Product Type
    • 2.2.5 By Application Type
    • 2.2.6 Japan
      • 2.2.6.1 By Product Type
      • 2.2.6.2 By Application Type
    • 2.2.7 China
      • 2.2.7.1 By Product Type
      • 2.2.7.2 By Application Type
    • 2.2.8 India
      • 2.2.8.1 By Product Type
      • 2.2.8.2 By Application Type
    • 2.2.9 Rest-of-Asia-Pacific
      • 2.2.9.1 By Product Type
      • 2.2.9.2 By Application Type

3 Mass Spectrometry and Chromatography in Diagnostics Market: Competitive Benchmarking and Company Profile

  • 3.1 Competitive Landscape
    • 3.1.1 Partnerships, Alliances, and Business Expansions
    • 3.1.2 New Offerings
    • 3.1.3 Mergers and Acquisitions
    • 3.1.4 Regulatory Approvals
  • 3.2 Key Strategies and Development
  • 3.3 Company Competition Matrix
  • 3.4 Company Share Analysis
  • 3.5 Company Profiles
    • 3.5.1 Shimadzu Corporation
      • 3.5.1.1 Overview
      • 3.5.1.2 Top Products
      • 3.5.1.3 Top Competitors
      • 3.5.1.4 Top Customers
      • 3.5.1.5 Key Personnel
      • 3.5.1.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation

List of Figures

  • Figure 1: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2024, 2028, and 2033
  • Figure 2: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023, 2027, and 2033
  • Figure 3: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Application), $Million, 2023, 2027, and 2033
  • Figure 4: Product Benchmarking (Mass Spectrometry and Chromatography (by Instruments))
  • Figure 5: Japan Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 6: China Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 7: India Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 8: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 9: Partnerships, Alliances, and Business Expansions, January 2015- June 2024
  • Figure 10: New Offerings, January 2015- June 2024
  • Figure 11: Mergers and Acquisitions, January 2015- June 2024
  • Figure 12: New Offerings, January 2015- June 2024
  • Figure 13: Mass Spectrometry and Chromatography in Diagnostics Market, Company Competition Matrix
  • Figure 14: Mass Spectrometry and Chromatography in Diagnostics Market, % Share, 2023
  • Figure 15: Data Triangulation
  • Figure 16: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Current State and Future Potential of Key Trends in the Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market
  • Table 3: Mass Spectrometry and Chromatography in Diagnostics Market (by Region), $Million, 2023-2033
  • Table 4: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 5: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 6: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 7: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 8: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 9: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 10: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 11: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 12: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 13: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 14: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 15: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 16: China Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 17: China Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 18: China Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 19: China Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 20: China Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 21: China Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 22: India Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 23: India Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 24: India Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 25: India Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 26: India Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 27: India Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 28: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 29: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 30: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 31: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 32: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 33: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 34: Mass Spectrometry and Chromatography in Diagnostics Market, Key Development Analysis, January 2015-June 2024